These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5164252)

  • 1. Response to warfarin in hypothyroid rats.
    McIntosh ; Waters L; Fouts ; Wilson WR
    Eur J Pharmacol; 1971 Apr; 14(2):176-82. PubMed ID: 5164252
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium warfarin.
    O'Reilly RA
    Pharmacology; 1972; 8(1):181-90. PubMed ID: 4644647
    [No Abstract]   [Full Text] [Related]  

  • 3. The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats.
    Hewick DS
    J Pharm Pharmacol; 1972 Aug; 24(8):661-2. PubMed ID: 4403752
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.
    Sellers EM; Koch-Weser J
    N Engl J Med; 1970 Oct; 283(16):827-31. PubMed ID: 5458032
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs.
    Sellers EM; Koch-Weser J
    Ann N Y Acad Sci; 1971 Jul; 179():213-25. PubMed ID: 5285376
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of effect of ranitidine on warfarin action.
    Serlin MJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1981 Dec; 12(6):791-4. PubMed ID: 6122462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary excretion of warfarin in rabbits: relationship between pharmacological effect and salivary pharmacokinetics of warfarin in rabbits.
    Sakai K; Nishiura A; Fujihara Y; Kutsuna T; Nishino T
    J Pharmacobiodyn; 1983 Dec; 6(12):991-9. PubMed ID: 6674482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin elimination and responsiveness in patients with renal dysfunction.
    Bachmann K; Shapiro R; Mackiewicz J
    J Clin Pharmacol; 1977; 17(5-6):292-9. PubMed ID: 858804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.
    Williams RL; Schary WL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Jul; 20(1):90-7. PubMed ID: 1277729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered plasma protein binding of drugs in thyroid disease.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacokinet; 1981; 6(4):298-305. PubMed ID: 7249488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats.
    Ogiso T; Iwaki M; Konishi Y
    J Pharmacobiodyn; 1982 Oct; 5(10):829-40. PubMed ID: 7161710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
    Slattery JT; Yacobi A; Levy G
    J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rodenticidal effect of warfarin. 3. Binding to serum proteins].
    Niedner R; von Oettingen U; Kayser M; Meyer F
    Arzneimittelforschung; 1974 Jul; 24(7):1039-43. PubMed ID: 4408103
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of dietary protein on the response of rats receiving toxic levels of warfarin.
    Barber DL; Colvin HW
    Toxicol Appl Pharmacol; 1980 Oct; 56(1):8-15. PubMed ID: 7444969
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteration of warfarin kinetics in man associated with exposure to an operating-room environment.
    Ghoneim MM; Delle M; Wilson WR; Ambre JJ
    Anesthesiology; 1975 Sep; 43(3):333-6. PubMed ID: 1163833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):552-8. PubMed ID: 1277711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man.
    Levy G; O'Reilly RA; Aggeler PM; Keech GM
    Clin Pharmacol Ther; 1970; 11(3):372-7. PubMed ID: 5445741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.